copd

AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma

Alpha-1 antitrypsin (AAT) protein extends its protective role beyond established AAT deficiency, influencing general lung health.

IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction

IL-33 acts as both a pro-inflammatory cytokine and a contributor to mucus hypersecretion in COPD, complicating therapeutic targeting.

Triple Therapy Optimises COPD Outcomes at ATS 2026

ATS 2026 presentations highlight tailored triple therapy for obstructive lung disease, improving lung function and reducing exacerbations.

Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances

ATS 2026 highlights mechanistic and multimodal approaches to obstructive sleep apnea, moving beyond CPAP to targeted therapies.

CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026

Cardiopulmonary exercise testing (CPET) continues to evolve, offering enhanced diagnostic and prognostic precision for various cardiopulmonary conditions. New applications presented at ATS 2026 highlight its utility beyond traditional indications.

ATS 2026: Ultrasound Education Advances for Clinical Practice

ATS 2026 highlights advancements in ultrasound practice and instruction, addressing variability in operator proficiency and diagnostic accuracy.

Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques

ATS 2026 will feature a hands-on guide to basic bronchoscopy, EBUS, and guided bronchoscopy, addressing the need for advanced procedural competency.